2019-07-01
MxA is a clinically applicable biomarker for type i interferon activation in systemic lupus erythematosus and systemic sclerosis
Publication
Publication
Rheumatology (United Kingdom) , Volume 58 - Issue 7 p. 1302- 1303
Additional Metadata | |
---|---|
doi.org/10.1093/rheumatology/kez078, hdl.handle.net/1765/117935 | |
VSNU Open Access deal | |
Rheumatology (United Kingdom) | |
Organisation | Department of Immunology |
Huijser, E. (Erika), van Helden-Meeuwsen, C., Groot, N., Bodewes, I., Wahadat, M.J. (M. Javad), Schreurs, M., … Versnel, M. (2019). MxA is a clinically applicable biomarker for type i interferon activation in systemic lupus erythematosus and systemic sclerosis. Rheumatology (United Kingdom), 58(7), 1302–1303. doi:10.1093/rheumatology/kez078 |